(Press-News.org) An emotion recognition tool - developed by University of the West of Scotland (UWS) academics - could help people with neurodiverse conditions including autism.
Traditionally, emotion recognition has been a challenging and complex area of study. However, with recent advancements in vision processing, and low-cost devices, such as wearable electroencephalogram (EEG) and electrocardiogram (ECG) sensors, UWS academics have collaborated to harness the power of these technologies to create artificial intelligence (AI) which can accurately read emotion-related signals from brain and facial analysis.
Professor Naeem Ramzan, Director of the Affective and Human Computing for SMART Environments Research Centre at UWS, said: "Emotions are a fundamental aspect of the human experience, and understanding the signals that trigger different emotions can have a profound impact on various aspects of our lives.
"Our recent study has led to the creation of comprehensive data which can be deployed with wearable technology – using multi-sensors and artificial intelligence – to provide a vital tool for emotion recognition. The data also provides a valuable resource for researchers and industry professionals, enabling them to have a greater understanding of emotional triggers, and providing a reference point which could unlock new possibilities for advancements in health and wellbeing, education and security.
The system uses a multimodal database, developed by UWS researchers, which consists of signals that were recorded during a study using audio-visual stimuli. Participants in the study were recorded and self-assessed their emotional reaction to each stimuli, in terms of reaction, stimulation, and dominance. Signals were captured using a camera and wearable, wireless equipment that has the potential to allow the use of affective computing methods in everyday applications.
This breakthrough could offer a new tool for clinicians, therapists, and caregivers to better understand the emotional states of individuals with a range of neurodiverse conditions; offering the potential to improve mental health assessments and enable early intervention for emotional challenges, opening up greater possibilities for personalised therapeutic interventions.
The technology could pave the way for the creation of augmented reality, virtual reality, or application in robotics specifically designed to assist individuals by understanding and expressing emotions.
END
AI could transform the way we understand emotion
2023-06-22
ELSE PRESS RELEASES FROM THIS DATE:
More positive outcomes when elderly are treated locally
2023-06-22
Older people with health problems often need some form of intermediate level monitoring, care and treatment services.
They may not need the resources of a hospital but do require somewhat more advanced help than a nursing home can usually offer. "Intermediate care units" are primarily intended to replace an acute hospital admission, but are occasionally also used following admission.
“Intermediate care units are the newest trend in health policy, and Norway is way ahead of the curve in this regard,” says Pål Erling Martinussen, a professor in the Department of Sociology and Political ...
The ACMG Releases 2023 Update to Secondary Findings Gene List; SF v3.2
2023-06-22
The American College of Medical Genetics and Genomics (ACMG) has released its highly anticipated 2023 update to the recommended minimum gene list for the reporting of secondary findings (SF): “ACMG SF v3.2 List for Reporting of Secondary Findings in Clinical Exome and Genome Sequencing: A Policy Statement of the American College of Medical Genetics and Genomics (ACMG).” In 2021, the ACMG Board of Directors and Secondary Findings Working Group (SFWG) stated that the College would update the list annually. Today’s update (SF v3.2) is being published in ACMG’s flagship journal, Genetics ...
Lupus Research Alliance honors Carola Vinuesa, MD, PhD, for discovering a specific gene variant that causes lupus in some patients
2023-06-22
NEW YORK, NY – June 22, 2023 – The Lupus Research Alliance awarded its 2023 Lupus Insight Prize to Carola Vinuesa, MD, PhD, of The Francis Crick Institute, for her seminal discovery that a mutation in a specific human gene causes systemic lupus erythematosus (SLE), uncovering an important target for the development of novel treatment. The Lupus Insight Prize is awarded each year to an outstanding investigator who has made a significant discovery that will advance our understanding of the pathogenesis, diagnosis, or treatment of lupus.
Dr. Vinuesa ...
Portable tool to diagnose and monitor sickle cell disease receives U.S. patent
2023-06-22
In the United States, sickle cell disease affects about 100,000 people and about 2 million Americans carry this genetic mutation. The most common and serious problems caused by sickle cell disease are anemia, pain and organ failure – stroke affects about 10 out of 100 children who have this disease. The national median life expectancy for people who have sickle cell disease can reach up to age 50.
This inherited, lifelong blood disorder is characterized by rigid and sickle-shaped red blood cells due to a dramatic change in their morphology. They stick to blood vessels, blocking ...
Model blood-brain barrier could improve newborn meningitis treatment
2023-06-22
Washington, D.C. – Investigators in Israel and Italy have developed a model of the blood-brain barrier, studies of which may lead to prevention of meningitis in newborns. The research is published in Microbiology Spectrum, a journal of the American Society for Microbiology.
The investigators further developed a platform called organs-on-a-chip—invented during the 2000s—to construct the model. These devices, which are modeled after microchips, contain tiny channels lined with living human ...
TTUHSC-TTU research collaboration leads to possible drug targets for Leishmaniasis
2023-06-22
Leishmaniasis is a tropical disease caused by parasites known as Leishmania, which are transmitted to humans and animals through the bites of more than 90 species of sand flies. Considered a neglected tropical disease, leishmaniasis is found in approximately 88 countries primarily located in South and Central America, the Middle East and western Asia. As many as 1 million new cases are diagnosed each year and more than 350 million people are at risk of infection. Some forms of the disease ...
'Poo transplant' trial provides hope for liver disease patients
2023-06-22
The UK is to launch a clinical trial of a ‘poo transplant’ that researchers believe could treat advanced liver disease and fight antimicrobial resistance.
The trial’s investigators also provide evidence for the first time that a faecal transplant can dramatically improve gut health.
The PROMISE trial is led by King’s College London and funded by a National Institute for Health and Care Research (NIHR) and Medical Research Council (MRC) partnership. It will recruit patients with cirrhosis from across the UK to test whether oral Faecal Microbiota Transplant (FMT) capsules from freeze-dried stool from healthy volunteers reduces the likelihood of getting an ...
The development of an online platform to promote customized self oral healthcare
2023-06-22
Alexandria, VA, USA – A study that introduces a new strategy to promote customized, oral health self-care by using an online platform to connect dental professionals and patients will be presented at the 101st General Session of the IADR, which will be held in conjunction with the 9th Meeting of the Latin American Region and the 12th World Congress on Preventive Dentistry on June 21-24, 2023, in Bogotá, Colombia.
The Interactive Talk presentation, “An Online Platform to Promote Customized Self Oral Healthcare,” will take place on Thursday, ...
Study examines the effect of university closures in Bolivia during COVID-19 pandemic on graduates’ self-confidence
2023-06-22
Alexandria, VA, USA – A study examining the effect of COVID-19 lockdowns on Bolivian dental school graduates will be presented at the 101st General Session of the IADR, which will be held in conjunction with the 9th Meeting of the Latin American Region and the 12th World Congress on Preventive Dentistry on June 21-24, 2023, in Bogotá, Colombia.
The Interactive Talk presentation, “Covid–19 Pandemic Effects on Graduates’ Self Confidence to Execute Dental Clinical Procedures,” will take place on Thursday, June 22, 2023, at 2 p.m. Colombia Time (UTC-05:00) during the “Attitude ...
Genetic mutations blunt immune defences in leukaemia-linked rare bone marrow disorder
2023-06-22
Patients with a rare genetic bone marrow disorder which puts them at increased risk of blood cancers could benefit from a discovery that may lead to new treatments to slow or reverse the disease.
In a new study published in Cell Reports, scientists from the University of Birmingham and University of Warwick have found that affected blood stem cells that are produced in bone marrow produce much fewer immune cells used to fight infection. The mutation in the GATA2 gene in these blood stem cells results in impaired ability to repair ongoing damage to their DNA and puts patients at risk of developing blood cancers. The median age for patients developing Acute Myeloid Leukaemia who ...